Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8294114 | 0.86 | TAAR1 (0.61) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL565564 | 0.84 | TAAR1 (0.48) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL12775573 | 0.83 | TAAR1 (0.56) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL9959103 | 0.82 | TAAR1 (0.44) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL20382761 | 0.82 | TAAR1 (0.44) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL29449712 | 0.81 | TAAR1 (0.49) | TAAR1CYP2D6LMNAGAAHPGD | |
| SCHEMBL14103267 | 0.81 | TAAR1 (0.49) | TAAR1CYP2D6LMNAGAAHPGD | |
| SCHEMBL180328 | 0.81 | TAAR1 (0.43) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL23731783 | 0.80 | TMEM97 (0.50) | CYP2D6 | |
| SCHEMBL5018909 | 0.79 | TAAR1 (0.59) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3149135-A2 | PERFUME COMPOSITIONS | Givaudan S.A. (CH) | 2017-04-05 | — | — | EP | claimed |
| WO-2015181257-A2 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2015-12-03 | — | — | WO | claimed |
| US-8344023-B2 | 2,5-di- and 2,2,5-trisubstituted di- and tetrahydrofuran derivatives and their use for the production of perfumes | GIVAUDAN SA (CH) | 2013-01-01 | — | — | US | disclosed |
| US-20100173999-A1 | 2,5-DI- and 2,2,5-Trisubstituted Di- and Tetrahydrofuran Derivatives and Their Use for the Production of Perfumes | GIVAUDAN SA (CH) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173999-A1 | 2,5-DI- and 2,2,5-Trisubstituted Di- and Tetrahydrofuran Derivatives and Their Use for the Production of Perfumes | COXFA4, DUOX2, DRD5 | TAAR1 2459/4885SLC6A2 4560/4885SLC6A4 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.